1. Home
  2. AYTU vs AMST Comparison

AYTU vs AMST Comparison

Compare AYTU & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • AMST
  • Stock Information
  • Founded
  • AYTU N/A
  • AMST 2017
  • Country
  • AYTU United States
  • AMST United States
  • Employees
  • AYTU N/A
  • AMST N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • AMST Computer Software: Prepackaged Software
  • Sector
  • AYTU Health Care
  • AMST Technology
  • Exchange
  • AYTU Nasdaq
  • AMST Nasdaq
  • Market Cap
  • AYTU 8.3M
  • AMST 7.4M
  • IPO Year
  • AYTU N/A
  • AMST 2020
  • Fundamental
  • Price
  • AYTU $2.59
  • AMST $2.24
  • Analyst Decision
  • AYTU
  • AMST
  • Analyst Count
  • AYTU 0
  • AMST 0
  • Target Price
  • AYTU N/A
  • AMST N/A
  • AVG Volume (30 Days)
  • AYTU 3.4M
  • AMST 20.8K
  • Earning Date
  • AYTU 05-14-2025
  • AMST 05-23-2025
  • Dividend Yield
  • AYTU N/A
  • AMST N/A
  • EPS Growth
  • AYTU N/A
  • AMST N/A
  • EPS
  • AYTU N/A
  • AMST N/A
  • Revenue
  • AYTU $77,232,000.00
  • AMST $86,115.00
  • Revenue This Year
  • AYTU N/A
  • AMST N/A
  • Revenue Next Year
  • AYTU $8.14
  • AMST N/A
  • P/E Ratio
  • AYTU N/A
  • AMST N/A
  • Revenue Growth
  • AYTU N/A
  • AMST N/A
  • 52 Week Low
  • AYTU $0.95
  • AMST $2.00
  • 52 Week High
  • AYTU $3.45
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 82.21
  • AMST 49.14
  • Support Level
  • AYTU $1.20
  • AMST $2.21
  • Resistance Level
  • AYTU $1.31
  • AMST $2.55
  • Average True Range (ATR)
  • AYTU 0.13
  • AMST 0.17
  • MACD
  • AYTU 0.05
  • AMST 0.03
  • Stochastic Oscillator
  • AYTU 74.52
  • AMST 41.51

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: